We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

InterStim Prospective Database

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00441935
Recruitment Status : Terminated (Shift in department's research interest)
First Posted : March 1, 2007
Last Update Posted : December 25, 2017
Information provided by (Responsible Party):

February 28, 2007
March 1, 2007
December 25, 2017
April 2004
December 16, 2016   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00441935 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
InterStim Prospective Database
InterStim Prospective Database for Outcomes Research
The study is to collect information from patient charts and patient questionnaires to evaluate the effects of nerve stimulation therapy on urinary dysfunction.

Men and women with urinary incontinence (leakage of urine), frequency, and bladder pain experience embarrassment, inconvenience, and a significant negative impact on their quality of life. Although traditional treatments such as medications, diet modification, and bladder training provide relief for some people, others do not experience improvement with these treatments. Recently, mechanical devices much like a heart pacemaker have been developed to stimulate the nerves (sacral and pudendal) responsible for controlling bladder function. During a two stage operation, a permanent electrical wire is implanted in the lower back and connected to a mechanical box (stimulator) implanted under the patients skin in the hip area.

Participants will be asked to complete a set of questionnaires (Intake Form, Urinary Incontinence Treatment Network (UITN) Sexual Activity Questionnaire, Interstitial Cystitis Symptom Index and Problem Index, voiding diary) within 60 days prior to the procedure. Preoperative clinical information such as primary diagnosis, history of failed therapies, and medical history will be collected from the physician office record, and operative information will be collected from the inpatient hospital record. After the two stage operation (3, 6, and 12 months, then yearly thereafter as long as the device is in place) participants will be sent questionnaires. Upon completion and return to the study site

Observational Model: Other
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
patients at least 18 years of age scheduled for sacral nerve stimulator implantation at William Beaumont Hospital, Royal Oak
  • Urinary Retention
  • Urinary Incontinence
  • Pelvic Pain
Device: Interstim Neuromodulation
Two stage procedure to implant an interstim device for neuromodulation.
Interstim Neuromodulation
Subjects undergoing implantation of an Interstim device for neuromodulation.
Intervention: Device: Interstim Neuromodulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 16, 2016
December 16, 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients at least 18 years of age scheduled for sacral nerve stimulator implantation at William Beaumont Hospital, Royal Oak, Michigan who give informed consent to participate in the project.

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Kenneth Peters, MD, William Beaumont Hospitals
Kenneth Peters, MD
William Beaumont Hospitals
Principal Investigator: Kenneth Peters, MD William Beaumont Hospitals
William Beaumont Hospitals
December 2017